Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT01104831
Other study ID # B2009:035
Secondary ID
Status Terminated
Phase Phase 3
First received April 14, 2010
Last updated May 3, 2017
Start date April 2010
Est. completion date November 2012

Study information

Verified date April 2011
Source University of Manitoba
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Consenting patients with proximal tibia fractures will be randomized to 10 degree or 21 degree cryotherapy sleeves. Time to discharge and complications will be monitored.

Primary outcome measure: Cost of Treatment (based on length of stay) Secondary outcome measures: Satisfaction/pain relief and narcotic requirement


Recruitment information / eligibility

Status Terminated
Enrollment 20
Est. completion date November 2012
Est. primary completion date August 2012
Accepts healthy volunteers No
Gender All
Age group 17 Years and older
Eligibility Inclusion Criteria:

- Skeletally mature

- Trauma patients with single-system musculoskeletal injuries.

- Proximal tibia fractures treated with open reduction and internal fixation.

- Unilateral proximal tibial injuries.

Exclusion Criteria:

- Previous ipsilateral knee surgery

- Upper extremity injuries impairing mobilization

- Pre-existing ipsilateral neurologic condition or acute ipsilateral neurologic injury

- Associated injuries impairing mobilization

- Suspected or confirmed compartment syndrome

- Open fractures

- Patients previously on narcotics

- Patients with impaired sensorium Concurrent head injury Intoxication

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Cryotherapy
cooled sleeve placed over fracture site.
Room temperature cuff
sleeve with room temperature water placed over fracture site.

Locations

Country Name City State
Canada Winnipeg Health Sciences Centre Winnipeg Manitoba

Sponsors (3)

Lead Sponsor Collaborator
University of Manitoba Orthopedic Research and Education Foundation, Orthopedic Trauma Association

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Cost 3 months
Secondary VAS Pain Score 2 weeks
Secondary Narcotic Requirements 2 weeks